+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
CRO in Clinical Trials Market - Global Forecast 2025-2030- Product Image
CRO in Clinical Trials Market - Global Forecast 2025-2030- Product Image
Sale

CRO in Clinical Trials Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 182 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6139801
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The contract research organization (CRO) market is rapidly evolving in response to growing complexity, new technology integration, and shifting global regulations in clinical trials. Senior leaders increasingly rely on CRO partnerships to enable expert trial management, data capture, and agile execution, supporting innovation amid changing commercial and compliance demands.

Market Snapshot of the Contract Research Organization Market

The contract research organization market is experiencing transformative shifts driven by rising complexity in clinical trial design, diversified sponsor requirements, and regulatory changes across major regions. With accelerated adoption of decentralized trial models and artificial intelligence in workflow automation, CROs are positioned as strategic collaborators for pharmaceutical, biotechnology, and medical device sponsors. Demand for tailored service portfolios, regional expertise, and robust digital platforms reflects ongoing industry evolution and the importance of efficiency, cost control, and patient-centric approaches within the market.

Scope & Segmentation in Contract Research Outsourcing

This report delivers detailed segmentation to help stakeholders navigate service offerings, therapeutic specialties, trial phases, end-users, and trial designs in today's dynamic CRO sector:

  • Service Types: Biostatistics, clinical trial management (phases I–IV), data management, clinical data warehouse, eClinical solutions, electronic data capture, laboratory services, central and integrated laboratory services, medical writing, patient recruitment, pharmacovigilance, regulatory affairs, and site management.
  • Therapeutic Areas: Cardiovascular (coronary artery disease, heart failure), endocrinology, infectious diseases (bacterial and viral), neurology (CNS and neurodegenerative disorders), oncology (hematological cancers, solid tumors), and respiratory.
  • Trial Phases: Phase I (first-in-human, multiple ascending dose, single ascending dose), Phase II (stage IIa, IIb), Phase III (stage IIIa, IIIb), and Phase IV.
  • End Users: Biotechnology companies (established and startups), medical device companies, and pharmaceutical companies (generic, large, mid-sized).
  • Trial Design: Interventional (randomized and nonrandomized controlled trials) and observational (case-control, cohort, cross-sectional studies).
  • Sponsorship Types: Academic, government, and industry-sponsored trials.
  • Trial Sites: Clinics, hospitals, and research institutes.
  • Geographic Coverage: Americas (United States—major states, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (21 key countries), and Asia-Pacific (12 countries including China, India, Japan, and Australia).
  • Key Companies: IQVIA Holdings Inc., Laboratory Corporation of America Holdings, Parexel International Corporation, ICON plc, Pharmaceutical Product Development, LLC, PRA Health Sciences, Inc., Syneos Health, Inc., Charles River Laboratories International, Inc., WuXi AppTec Co., Ltd., Medpace Holdings, Inc.

Key Takeaways for Decision-Makers

  • End-to-end service portfolios are now a baseline expectation as sponsors seek seamless trial management, data analytics, and laboratory integration.
  • Decentralized and risk-based approaches are reshaping clinical development, advancing patient access and operational flexibility while enhancing data accuracy.
  • Strategic partnerships and tech-enabled collaborations are increasing, enabling sponsors to adapt service models to evolving therapeutic areas and regional regulatory landscapes.
  • Segmentation insights reveal a diverse spectrum of CRO clients, with precise demand variations by trial phase, therapeutic area, and organization size driving the need for tailored offerings.
  • Regional expertise—including infrastructure readiness, regulatory harmonization, and site access—directly impacts trial timelines and patient recruitment strategies.

Impact of U.S. Tariffs on Clinical Trial Supply Chains

The United States’ introduction of new tariffs in 2025 has imposed additional costs and operational complexities on clinical trial supply chains, notably affecting laboratory reagents and high-precision devices. These changes have prompted CROs and sponsors to reassess procurement, diversify supplier agreements, and explore regional nearshoring to mitigate customs delays and increased regulatory scrutiny. Proactive supply chain strategies are now essential to maintain operational agility and ensure uninterrupted trial progress.

Methodology & Data Sources for CRO Market Analysis

The analysis draws on a multi-phase methodology combining primary interviews with industry executives, regulatory advisors, and sponsor operations leads, along with systematic reviews of peer-reviewed literature, agency guidance, and global clinical trial registries. Quantitative data were validated by subject-matter experts through triangulation and SWOT and Porter’s Five Forces frameworks, ensuring robust, actionable insights for industry stakeholders.

Why This Report Matters to Senior Decision-Makers

  • Empowers leaders to shape clinical development roadmaps with risk-mitigation strategies, supply chain resilience, and future-ready service models.
  • Delivers actionable recommendations for optimizing CRO selection, leveraging digital transformation, and responding to regulatory or regional shifts in trial oversight.
  • Equips organizations to benchmark against leading CROs, monitor competitor moves, and align service delivery with sponsor needs in a dynamic environment.

Conclusion

The contract research organization market is adapting rapidly to technological, regulatory, and supply chain developments. Leaders who act on these insights and foster agile, strategically resourced partnerships will be poised to optimize clinical trials and advance therapeutic innovation.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of decentralized and hybrid trial models leveraging home health services
5.2. Adoption of real-world data and artificial intelligence for trial design and patient recruitment optimization
5.3. Strategic partnerships between biotech startups and mid-tier CROs for early-phase personalized medicine trials
5.4. Use of blockchain technology to ensure data integrity and transparency in multicenter clinical trials
5.5. Expansion of central laboratory and biomarker analysis capabilities for immuno-oncology endpoints
5.6. Implementation of adaptive trial designs enabled by predictive analytics and real-time data monitoring
5.7. Growth of patient-centric digital engagement platforms to improve retention in rare disease studies
5.8. Demand for seamless interoperability between EDC and CDMS systems to accelerate study timelines
5.9. Surge in demand for site-less trial capabilities integrating telemedicine and remote monitoring devices
5.10. Increasing regulatory scrutiny on data privacy and security protocols in decentralized trial platforms
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. CRO in Clinical Trials Market, by Service Type
8.1. Introduction
8.2. Biostatistics
8.3. Clinical Trial Management
8.3.1. Phase I
8.3.2. Phase II
8.3.3. Phase III
8.3.4. Phase IV
8.4. Data Management
8.4.1. Clinical Data Warehouse
8.4.2. eClinical Solutions
8.4.3. Electronic Data Capture
8.5. Laboratory Services
8.5.1. Central Laboratory
8.5.2. Integrated Laboratory Services
8.6. Medical Writing
8.7. Patient Recruitment
8.8. Pharmacovigilance
8.9. Regulatory Affairs
8.10. Site Management
9. CRO in Clinical Trials Market, by Therapeutic Area
9.1. Introduction
9.2. Cardiovascular
9.2.1. Coronary Artery Disease
9.2.2. Heart Failure
9.3. Endocrinology
9.4. Infectious Diseases
9.4.1. Bacterial Infections
9.4.2. Viral Infections
9.5. Neurology
9.5.1. Central Nervous System Disorders
9.5.2. Neurodegenerative Disorders
9.6. Oncology
9.6.1. Hematological Cancers
9.6.2. Solid Tumors
9.7. Respiratory
10. CRO in Clinical Trials Market, by Phase
10.1. Introduction
10.2. Phase I
10.2.1. First-In-Human
10.2.2. Multiple Ascending Dose
10.2.3. Single Ascending Dose
10.3. Phase II
10.3.1. Stage IIa
10.3.2. Stage IIb
10.4. Phase III
10.4.1. Stage IIIa
10.4.2. Stage IIIb
10.5. Phase IV
11. CRO in Clinical Trials Market, by End User
11.1. Introduction
11.2. Biotechnology Companies
11.2.1. Established Biotech
11.2.2. Startups
11.3. Medical Device Companies
11.4. Pharmaceutical Companies
11.4.1. Generic Pharma
11.4.2. Large Pharma
11.4.3. Mid-Sized Pharma
12. CRO in Clinical Trials Market, by Trial Design
12.1. Introduction
12.2. Interventional
12.2.1. Nonrandomized Trials
12.2.2. Randomized Controlled Trials
12.3. Observational
12.3.1. Case-Control Studies
12.3.2. Cohort Studies
12.3.3. Cross-Sectional Studies
13. CRO in Clinical Trials Market, by Sponsorship
13.1. Introduction
13.2. Academic Sponsored
13.3. Government Sponsored
13.4. Industry Sponsored
14. CRO in Clinical Trials Market, by Trial Site
14.1. Introduction
14.2. Clinic
14.3. Hospital
14.4. Research Institute
15. Americas CRO in Clinical Trials Market
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. Argentina
16. Europe, Middle East & Africa CRO in Clinical Trials Market
16.1. Introduction
16.2. United Kingdom
16.3. Germany
16.4. France
16.5. Russia
16.6. Italy
16.7. Spain
16.8. United Arab Emirates
16.9. Saudi Arabia
16.10. South Africa
16.11. Denmark
16.12. Netherlands
16.13. Qatar
16.14. Finland
16.15. Sweden
16.16. Nigeria
16.17. Egypt
16.18. Turkey
16.19. Israel
16.20. Norway
16.21. Poland
16.22. Switzerland
17. Asia-Pacific CRO in Clinical Trials Market
17.1. Introduction
17.2. China
17.3. India
17.4. Japan
17.5. Australia
17.6. South Korea
17.7. Indonesia
17.8. Thailand
17.9. Philippines
17.10. Malaysia
17.11. Singapore
17.12. Vietnam
17.13. Taiwan
18. Competitive Landscape
18.1. Market Share Analysis, 2024
18.2. FPNV Positioning Matrix, 2024
18.3. Competitive Analysis
18.3.1. IQVIA Holdings Inc.
18.3.2. Laboratory Corporation of America Holdings
18.3.3. Parexel International Corporation
18.3.4. ICON plc
18.3.5. Pharmaceutical Product Development, LLC
18.3.6. PRA Health Sciences, Inc.
18.3.7. Syneos Health, Inc.
18.3.8. Charles River Laboratories International, Inc.
18.3.9. WuXi AppTec Co., Ltd.
18.3.10. Medpace Holdings, Inc.
19. ResearchAI
20. ResearchStatistics
21. ResearchContacts
22. ResearchArticles
23. Appendix
List of Figures
FIGURE 1. CRO IN CLINICAL TRIALS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY SERVICE TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY SERVICE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY PHASE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY PHASE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY TRIAL DESIGN, 2024 VS 2030 (%)
FIGURE 14. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY TRIAL DESIGN, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY SPONSORSHIP, 2024 VS 2030 (%)
FIGURE 16. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY SPONSORSHIP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY TRIAL SITE, 2024 VS 2030 (%)
FIGURE 18. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY TRIAL SITE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS CRO IN CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS CRO IN CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES CRO IN CLINICAL TRIALS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES CRO IN CLINICAL TRIALS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA CRO IN CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA CRO IN CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC CRO IN CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC CRO IN CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. CRO IN CLINICAL TRIALS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. CRO IN CLINICAL TRIALS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 29. CRO IN CLINICAL TRIALS MARKET: RESEARCHAI
FIGURE 30. CRO IN CLINICAL TRIALS MARKET: RESEARCHSTATISTICS
FIGURE 31. CRO IN CLINICAL TRIALS MARKET: RESEARCHCONTACTS
FIGURE 32. CRO IN CLINICAL TRIALS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. CRO IN CLINICAL TRIALS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY BIOSTATISTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY BIOSTATISTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY CLINICAL TRIAL MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY CLINICAL TRIAL MANAGEMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY PHASE I, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY PHASE I, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY PHASE II, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY PHASE II, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY PHASE III, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY PHASE III, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY PHASE IV, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY PHASE IV, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY CLINICAL TRIAL MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY CLINICAL TRIAL MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY DATA MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY DATA MANAGEMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY CLINICAL DATA WAREHOUSE, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY CLINICAL DATA WAREHOUSE, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY ECLINICAL SOLUTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY ECLINICAL SOLUTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY ELECTRONIC DATA CAPTURE, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY ELECTRONIC DATA CAPTURE, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY DATA MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY DATA MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY LABORATORY SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY LABORATORY SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY CENTRAL LABORATORY, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY CENTRAL LABORATORY, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY INTEGRATED LABORATORY SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY INTEGRATED LABORATORY SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY LABORATORY SERVICES, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY LABORATORY SERVICES, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY MEDICAL WRITING, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY MEDICAL WRITING, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY PATIENT RECRUITMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY PATIENT RECRUITMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY PHARMACOVIGILANCE, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY PHARMACOVIGILANCE, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY REGULATORY AFFAIRS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY REGULATORY AFFAIRS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY SITE MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY SITE MANAGEMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY CORONARY ARTERY DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY CORONARY ARTERY DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY HEART FAILURE, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY HEART FAILURE, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY ENDOCRINOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY ENDOCRINOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY BACTERIAL INFECTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY BACTERIAL INFECTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY VIRAL INFECTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY VIRAL INFECTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY NEUROLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY CENTRAL NERVOUS SYSTEM DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY CENTRAL NERVOUS SYSTEM DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY NEURODEGENERATIVE DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY NEURODEGENERATIVE DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY HEMATOLOGICAL CANCERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY HEMATOLOGICAL CANCERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY SOLID TUMORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY SOLID TUMORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY RESPIRATORY, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY RESPIRATORY, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY PHASE, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY PHASE I, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY PHASE I, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY FIRST-IN-HUMAN, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY FIRST-IN-HUMAN, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY MULTIPLE ASCENDING DOSE, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY MULTIPLE ASCENDING DOSE, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY SINGLE ASCENDING DOSE, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY SINGLE ASCENDING DOSE, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY PHASE I, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY PHASE I, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY PHASE II, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY PHASE II, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY STAGE IIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY STAGE IIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY STAGE IIB, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY STAGE IIB, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY PHASE II, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY PHASE II, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY PHASE III, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY PHASE III, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY STAGE IIIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY STAGE IIIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY STAGE IIIB, BY REGION, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY STAGE IIIB, BY REGION, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY PHASE III, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY PHASE III, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY PHASE IV, BY REGION, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY PHASE IV, BY REGION, 2025-2030 (USD MILLION)
TABLE 121. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 122. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 123. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 124. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 125. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY ESTABLISHED BIOTECH, BY REGION, 2018-2024 (USD MILLION)
TABLE 126. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY ESTABLISHED BIOTECH, BY REGION, 2025-2030 (USD MILLION)
TABLE 127. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY STARTUPS, BY REGION, 2018-2024 (USD MILLION)
TABLE 128. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY STARTUPS, BY REGION, 2025-2030 (USD MILLION)
TABLE 129. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2024 (USD MILLION)
TABLE 130. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2025-2030 (USD MILLION)
TABLE 131. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY MEDICAL DEVICE COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 132. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY MEDICAL DEVICE COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 133. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 134. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 135. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY GENERIC PHARMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 136. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY GENERIC PHARMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 137. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY LARGE PHARMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 138. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY LARGE PHARMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 139. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY MID-SIZED PHARMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 140. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY MID-SIZED PHARMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 141. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 142. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 143. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY TRIAL DESIGN, 2018-2024 (USD MILLION)
TABLE 144. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY TRIAL DESIGN, 2025-2030 (USD MILLION)
TABLE 145. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY INTERVENTIONAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 146. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY INTERVENTIONAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 147. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY NONRANDOMIZED TRIALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 148. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY NONRANDOMIZED TRIALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 149. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY RANDOMIZED CONTROLLED TRIALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 150. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY RANDOMIZED CONTROLLED TRIALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 151. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY INTERVENTIONAL, 2018-2024 (USD MILLION)
TABLE 152. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY INTERVENTIONAL, 2025-2030 (USD MILLION)
TABLE 153. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY OBSERVATIONAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 154. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY OBSERVATIONAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 155. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY CASE-CONTROL STUDIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 156. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY CASE-CONTROL STUDIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 157. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY COHORT STUDIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 158. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY COHORT STUDIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 159. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY CROSS-SECTIONAL STUDIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 160. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY CROSS-SECTIONAL STUDIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 161. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY OBSERVATIONAL, 2018-2024 (USD MILLION)
TABLE 162. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY OBSERVATIONAL, 2025-2030 (USD MILLION)
TABLE 163. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY SPONSORSHIP, 2018-2024 (USD MILLION)
TABLE 164. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY SPONSORSHIP, 2025-2030 (USD MILLION)
TABLE 165. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY ACADEMIC SPONSORED, BY REGION, 2018-2024 (USD MILLION)
TABLE 166. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY ACADEMIC SPONSORED, BY REGION, 2025-2030 (USD MILLION)
TABLE 167. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY GOVERNMENT SPONSORED, BY REGION, 2018-2024 (USD MILLION)
TABLE 168. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY GOVERNMENT SPONSORED, BY REGION, 2025-2030 (USD MILLION)
TABLE 169. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY INDUSTRY SPONSORED, BY REGION, 2018-2024 (USD MILLION)
TABLE 170. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY INDUSTRY SPONSORED, BY REGION, 2025-2030 (USD MILLION)
TABLE 171. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY TRIAL SITE, 2018-2024 (USD MILLION)
TABLE 172. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY TRIAL SITE, 2025-2030 (USD MILLION)
TABLE 173. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY CLINIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 174. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY CLINIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 175. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 176. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 177. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY RESEARCH INSTITUTE, BY REGION, 2018-2024 (USD MILLION)
TABLE 178. GLOBAL CRO IN CLINICAL TRIALS MARKET SIZE, BY RESEARCH INSTITUTE, BY REGION, 2025-2030 (USD MILLION)
TABLE 179. AMERICAS CRO IN CLINICAL TRIALS MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 180. AMERICAS CRO IN CLINICAL TRIALS MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 181. AMERICAS CRO IN CLINICAL TRIALS MARKET SIZE, BY CLINICAL TRIAL MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 182. AMERICAS CRO IN CLINICAL TRIALS MARKET SIZE, BY CLINICAL TRIAL MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 183. AMERICAS CRO IN CLINICAL TRIALS MARKET SIZE, BY DATA MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 184. AMERICAS CRO IN CLINICAL TRIALS MARKET SIZE, BY DATA MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 185. AMERICAS CRO IN CLINICAL TRIALS MARKET SIZE, BY LABORATORY SERVICES, 2018-2024 (USD MILLION)
TABLE 186. AMERICAS CRO IN CLINICAL TRIALS MARKET SIZE, BY LABORATORY SERVICES, 2025-2030 (USD MILLION)
TABLE 187. AMERICAS CRO IN CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 188. AMERICAS CRO IN CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 189. AMERICAS CRO IN CLINICAL TRIALS MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 190. AMERICAS CRO IN CLINICAL TRIALS MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 191. AMERICAS CRO IN CLINICAL TRIALS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 192. AMERICAS CRO IN CLINICAL TRIALS MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 193. AMERICAS CRO IN CLINICAL TRIALS MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 194. AMERICAS CRO IN CLINICAL TRIALS MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 195. AMERICAS CRO IN CLINICAL TRIALS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 196. AMERICAS CRO IN CLINICAL TRIALS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 197. AMERICAS CRO IN CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2024 (USD MILLION)
TABLE 198. AMERICAS CRO IN CLINICAL TRIALS MARKET SIZE, BY PHASE, 2025-2030 (USD MILLION)
TABLE 199. AMERICAS CRO IN CLINICAL TRIALS MARKET SIZE, BY PHASE I, 2018-2024 (USD MILLION)
TABLE 200. AMERICAS CRO IN CLINICAL TRIALS MARKET SIZE, BY PHASE I, 2025-2030 (USD MILLION)
TABLE 201. AMERICAS CRO IN CLINICAL TRIALS MARKET SIZE, BY PHASE II, 2018-2024 (USD MILLION)
TABLE 202. AMERICAS CRO IN CLINICAL TRIALS MARKET SIZE, BY PHASE II, 2025-2030 (USD MILLION)
TABLE 203. AMERICAS CRO IN CLINICAL TRIALS MARKET SIZE, BY PHASE III, 2018-2024 (USD MILLION)
TABLE 204. AMERICAS CRO IN CLINICAL TRIALS MARKET SIZE, BY PHASE III, 2025-2030 (USD MILLION)
TABLE 205. AMERICAS CRO IN CLINICAL TRIALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 206. AMERICAS CRO IN CLINICAL TRIALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 207. AMERICAS CRO IN CLINICAL TRIALS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2024 (USD MILLION)
TABLE 208. AMERICAS CRO IN CLINICAL TRIALS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2025-2030 (USD MILLION)
TABLE 209. AMERICAS CRO IN CLINICAL TRIALS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 210. AMERICAS CRO IN CLINICAL TRIALS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 211. AMERICAS CRO IN CLINICAL TRIALS MARKET SIZE, BY TRIAL DESIGN, 2018-2024 (USD MILLION)
TABLE 212. AMERICAS CRO IN CLINICAL TRIALS MARKET SIZE, BY TRIAL DESIGN, 2025-2030 (USD MILLION)
TABLE 213. AMERICAS CRO IN CLINICAL TRIALS MARKET SIZE, BY INTERVENTIONAL, 2018-2024 (USD MILLION)
TABLE 214. AMERICAS CRO IN CLINICAL TRIALS MARKET SIZE, BY INTERVENTIONAL, 2025-2030 (USD MILLION)
TABLE 215. AMERICAS CRO IN CLINICAL TRIALS MARKET SIZE, BY OBSERVATIONAL, 2018-2024 (USD MILLION)
TABLE 216. AMERICAS CRO IN CLINICAL TRIALS MARKET SIZE, BY OBSERVATIONAL, 2025-2030 (USD MILLION)
TABLE 217. AMERICAS CRO IN CLINICAL TRIALS MARKET SIZE, BY SPONSORSHIP, 2018-2024 (USD MILLION)
TABLE 218. AMERICAS CRO IN CLINICAL TRIALS MARKET SIZE, BY SPONSORSHIP, 2025-2030 (USD MILLION)
TABLE 219. AMERICAS CRO IN CLINICAL TRIALS MARKET SIZE, BY TRIAL SITE, 2018-2024 (USD MILLION)
TABLE 220. AMERICAS CRO IN CLINICAL TRIALS MARKET SIZE, BY TRIAL SITE, 2025-2030 (USD MILLION)
TABLE 221. AMERICAS CRO IN CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 222. AMERICAS CRO IN CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 223. UNITED STATES CRO IN CLINICAL TRIALS MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 224. UNITED STATES CRO IN CLINICAL TRIALS MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 225. UNITED STATES CRO IN CLINICAL TRIALS MARKET SIZE, BY CLINICAL TRIAL MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 226. UNITED STATES CRO IN CLINICAL TRIALS MARKET SIZE, BY CLINICAL TRIAL MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 227. UNITED STATES CRO IN CLINICAL TRIALS MARKET SIZE, BY DATA MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 228. UNITED STATES CRO IN CLINICAL TRIALS MARKET SIZE, BY DATA MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 229. UNITED STATES CRO IN CLINICAL TRIALS MARKET SIZE, BY LABORATORY SERVICES, 2018-2024 (USD MILLION)
TABLE 230. UNITED STATES CRO IN CLINICAL TRIALS MARKET SIZE, BY LABORATORY SERVICES, 2025-2030 (USD MILLION)
TABLE 231. UNITED STATES CRO IN CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 232. UNITED STATES CRO IN CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 233. UNITED STATES CRO IN CLINICAL TRIALS MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 234. UNITED STATES CRO IN CLINICAL TRIALS MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 235. UNITED STATES CRO IN CLINICAL TRIALS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 236. UNITED STATES CRO IN CLINICAL TRIALS MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 237. UNITED STATES CRO IN CLINICAL TRIALS MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 238. UNITED STATES CRO IN CLINICAL TRIALS MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 239. UNITED STATES CRO IN CLINICAL TRIALS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 240. UNITED STATES CRO IN CLINICAL TRIALS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 241. UNITED STATES CRO IN CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2024 (USD MILLION)
TABLE 242. UNITED STATES CRO IN CLINICAL TRIALS MARKET SIZE, BY PHASE, 2025-2030 (USD MILLION)
TABLE 243. UNITED STATES CRO IN CLINICAL TRIALS MARKET SIZE, BY PHASE I, 2018-2024 (USD MILLION)
TABLE 244. UNITED STATES CRO IN CLINICAL TRIALS MARKET SIZE, BY PHASE I, 2025-2030 (USD MILLION)
TABLE 245. UNITED STATES CRO IN CLINICAL TRIALS MARKET SIZE, BY PHASE II, 2018-2024 (USD MILLION)
TABLE 246. UNITED STATES CRO IN CLINICAL TRIALS MARKET SIZE, BY PHASE II, 2025-2030 (USD MILLION)
TABLE 247. UNITED STATES CRO IN CLINICAL TRIALS MARKET SIZE, BY PHASE III, 2018-2024 (USD MILLION)
TABLE 248. UNITED STATES CRO IN CLINICAL TRIALS MARKET SIZE, BY PHASE III, 2025-2030 (USD MILLION)
TABLE 249. UNITED STATES CRO IN CLINICAL TRIALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 250. UNITED STATES CRO IN CLINICAL TRIALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 251. UNITED STATES CRO IN CLINICAL TRIALS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2024 (USD MILLION)
TABLE 252. UNITED STATES CRO IN CLINICAL TRIALS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2025-2030 (USD MILLION)
TABLE 253. UNITED STATES CRO IN CLINICAL TRIALS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 254. UNITED STATES CRO IN CLINICAL TRIALS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 255. UNITED STATES CRO IN CLINICAL TRIALS MARKET SIZE, BY TRIAL DESIGN, 2018-2024 (USD MILLION)
TABLE 256. UNITED STATES CRO IN CLINICAL TRIALS MARKET SIZE, BY TRIAL DESIGN, 2025-2030 (USD MILLION)
TABLE 257. UNITED STATES CRO IN CLINICAL TRIALS MARKET SIZE, BY INTERVENTIONAL, 2018-2024 (USD MILLION)
TABLE 258. UNITED STATES CRO IN CLINICAL TRIALS MARKET SIZE, BY INTERVENTIONAL, 2025-2030 (USD MILLION)
TABLE 259. UNITED STATES CRO IN CLINICAL TRIALS MARKET SIZE, BY OBSERVATIONAL, 2018-2024 (USD MILLION)
TABLE 260. UNITED STATES CRO IN CLINICAL TRIALS MARKET SIZE, BY OBSERVATIONAL, 2025-2030 (USD MILLION)
TABLE 261. UNITED STATES CRO IN CLINICAL TRIALS MARKET SIZE, BY SPONSORSHIP, 2018-2024 (USD MILLION)
TABLE 262. UNITED STATES CRO IN CLINICAL TRIALS MARKET SIZE, BY SPONSORSHIP, 2025-2030 (USD MILLION)
TABLE 263. UNITED STATES CRO IN CLINICAL TRIALS MARKET SIZE, BY TRIAL SITE, 2018-2024 (USD MILLION)
TABLE 264. UNITED STATES CRO IN CLINICAL TRIALS MARKET SIZE, BY TRIAL SITE, 2025-2030 (USD MILLION)
TABLE 265. UNITED STATES CRO IN CLINICAL TRIALS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 266. UNITED STATES CRO IN CLINICAL TRIALS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 267. CANADA CRO IN CLINICAL TRIALS MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 268. CANADA CRO IN CLINICAL TRIALS MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 269. CANADA CRO IN CLINICAL TRIALS MARKET SIZE, BY CLINICAL TRIAL MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 270. CANADA CRO IN CLINICAL TRIALS MARKET SIZE, BY CLINICAL TRIAL MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 271. CANADA CRO IN CLINICAL TRIALS MARKET SIZE, BY DATA MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 272. CANADA CRO IN CLINICAL TRIALS MARKET SIZE, BY DATA MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 273. CANADA CRO IN CLINICAL TRIALS MARKET SIZE, BY LABORATORY SERVICES, 2018-2024 (USD MILLION)
TABLE 274. CANADA CRO IN CLINICAL TRIALS MARKET SIZE, BY LABORATORY SERVICES, 2025-2030 (USD MILLION)
TABLE 275. CANADA CRO IN CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 276. CANADA CRO IN CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 277. CANADA CRO IN CLINICAL TRIALS MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 278. CANADA CRO IN CLINICAL TRIALS MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 279. CANADA CRO IN CLINICAL TRIALS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 280. CANADA CRO IN CLINICAL TRIALS MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 281. CANADA CRO IN CLINICAL TRIALS MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 282. CANADA CRO IN CLINICAL TRIALS MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 283. CANADA CRO IN CLINICAL TRIALS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 284. CANADA CRO IN CLINICAL TRIALS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 285. CANADA CRO IN CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2024 (USD MILLION)
TABLE 286. CANADA CRO IN CLINICAL TRIALS MARKET SIZE, BY PHASE, 2025-2030 (USD MILLION)
TABLE 287. CANADA CRO IN CLINICAL TRIALS MARKET SIZE, BY PHASE I, 2018-2024 (USD MILLION)
TABLE 288. CANADA CRO IN CLINICAL TRIALS MARKET SIZE, BY PHASE I, 2025-2030 (USD MILLION)
TABLE 289. CANADA CRO IN CLINICAL TRIALS MARKET SIZE, BY PHASE II, 2018-2024 (USD MILLION)
TABLE 290. CANADA CRO IN CLINICAL TRIALS MARKET SIZE, BY PHASE II, 2025-2030 (USD MILLION)
TABLE 291. CANADA CRO IN CLINICAL TRIALS MARKET SIZE, BY PHASE III, 2018-2024 (USD MILLION)
TABLE 292. CANADA CRO IN CLINICAL TRIALS MARKET SIZE, BY PHASE III, 2025-2030 (USD MILLION)
TABLE 293. CANADA CRO IN CLINICAL TRIALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 294. CANADA CRO IN CLINICAL TRIALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 295. CANADA CRO IN CLINICAL TRIALS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2024 (USD MILLION)
TABLE 296. CANADA CRO IN CLINICAL TRIALS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2025-2030 (USD MILLION)
TABLE 297. CANADA CRO IN CLINICAL TRIALS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 298. CANADA CRO IN CLINICAL TRIALS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 299. CANADA CRO IN CLINICAL TRIALS MARKET SIZE, BY TRIAL DESIGN, 2018-2024 (USD MILLION)
TABLE 300. CANADA CRO IN CLINICAL TRIALS MARKET SIZE, BY TRIAL DESIGN, 2025-2030 (USD MILLION)
TABLE 301. CANADA CRO IN CLINICAL TRIALS MARKET SIZE, BY INTERVENTIONAL, 2018-2024 (USD MILLION)
TABLE 302. CANADA CRO IN CLINICAL TRIALS MARKET SIZE, BY INTERVENTIONAL, 2025-2030 (USD MILLION)
TABLE 303. CANADA CRO IN CLINICAL TRIALS MARKET SIZE, BY OBSERVATIONAL, 2018-2024 (USD MILLION)
TABLE 304. CANADA CRO IN CLINICAL TRIALS MARKET SIZE, BY OBSERVATIONAL, 2025-2030 (USD MILLION)
TABLE 305. CANADA CRO IN CLINICAL TRIALS MARKET SIZE, BY SPONSORSHIP, 2018-2024 (USD MILLION)
TABLE 306. CANADA CRO IN CLINICAL TRIALS MARKET SIZE, BY SPONSORSHIP, 2025-2030 (USD MILLION)
TABLE 307. CANADA CRO IN CLINICAL TRIALS MARKET SIZE, BY TRIAL SITE, 2018-2024 (USD MILLION)
TABLE 308. CANADA CRO IN CLINICAL TRIALS MARKET SIZE, BY TRIAL SITE, 2025-2030 (USD MILLION)
TABLE 309. MEXICO CRO IN CLINICAL TRIALS MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 310. MEXICO CRO IN CLINICAL TRIALS MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 311. MEXICO CRO IN CLINICAL TRIALS MARKET SIZE, BY CLINICAL TRIAL MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 312. MEXICO CRO IN CLINICAL TRIALS MARKET SIZE, BY CLINICAL TRIAL MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 313. MEXICO CRO IN CLINICAL TRIALS MARKET SIZE, BY DATA MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 314. MEXICO CRO IN CLINICAL TRIALS MARKET SIZE, BY DATA MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 315. MEXICO CRO IN CLINICAL TRIALS MARKET SIZE, BY LABORATORY SERVICES, 2018-2024 (USD MILLION)
TABLE 316. MEXICO CRO IN CLINICAL TRIALS MARKET SIZE, BY LABORATORY SERVICES, 2025-2030 (USD MILLION)
TABLE 317. MEXICO CRO IN CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 318. MEXICO CRO IN CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 319. MEXICO CRO IN CLINICAL TRIALS MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 320. MEXICO CRO IN CLINICAL TRIALS MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 321

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this CRO in Clinical Trials market report include:
  • IQVIA Holdings Inc.
  • Laboratory Corporation of America Holdings
  • Parexel International Corporation
  • ICON plc
  • Pharmaceutical Product Development, LLC
  • PRA Health Sciences, Inc.
  • Syneos Health, Inc.
  • Charles River Laboratories International, Inc.
  • WuXi AppTec Co., Ltd.
  • Medpace Holdings, Inc.

Related Topics

Related Reports

Imaging CRO Market - Global Forecast 2025-2030 - Product Image

Imaging CRO Market - Global Forecast 2025-2030

  • Report
  • 191 Pages
  • Global
From
Contract Research Organization (CRO) Services: Global Markets - Product Image

Contract Research Organization (CRO) Services: Global Markets

  • Report
  • 169 Pages
  • Global
From
In Vivo CRO Market Size, Share & Trends Analysis Report By Model Type, By Modality, By Indication, By GLP Type, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

In Vivo CRO Market Size, Share & Trends Analysis Report By Model Type, By Modality, By Indication, By GLP Type, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 150 Pages
  • Global
From
Contract Research Organisation (CRO) Services Market Size and Share - Outlook Report, Forecast Trends and Growth Analysis (2025-2034) - Product Image

Contract Research Organisation (CRO) Services Market Size and Share - Outlook Report, Forecast Trends and Growth Analysis (2025-2034)

  • Report
  • 400 Pages
  • Global
From
Healthcare CRO Services Market Report 2025 - Product Image

Healthcare CRO Services Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.